Epithelial innate immune response to Acinetobacter baumannii challenge

Infection and Immunity

Volumn 82, Issue 11, 2014, Pages 4458-4465

  Feng, Zhimin ^a   Jia, Xun ^a   Adams, Mark D ^b   Ghosh, Santosh K ^a   Bonomo, Robert A ^a,c   Weinberg, Aaron ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b J CRAIG VENTER INSTITUTE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; BETA DEFENSIN 2; BETA DEFENSIN 3; DISINTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; 3-(FORMYLHYDROXYAMINO)-2-(3-PHENYL-1-PROPYL)BUTANOIC ACID (2,2-DIMETHYL-1-METHYLCARBAMOYL-1-PROPYL)AMIDE; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; BETA DEFENSIN; DIPEPTIDE; HYDROXAMIC ACID; MEMBRANE PROTEIN; SECRETASE; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL IMMUNITY; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; MOUTH MUCOSA; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN EPITHELIUM; ANTAGONISTS AND INHIBITORS; COCULTURE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ACINETOBACTER BAUMANNII; ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; BETA-DEFENSINS; COCULTURE TECHNIQUES; DIPEPTIDES; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; HYDROXAMIC ACIDS; IMMUNITY, INNATE; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84907960585     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01897-14     Document Type: Article

References (42)

1. Murray CK, Hospenthal DR. 2005. Treatment of multidrug resistant Acinetobacter. Curr. Opin. Infect. Dis. 18:502-506. http://dx.doi.org/10.1097/01.qco.0000185985.64759.41.
2. Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, Quinn JP, Doern GV. 2007. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J. Clin. Microbiol. 45:3352-3359. http://dx.doi.org/10.1128/JCM.01284-07.
3. Lee JC, Koerten H, van den Broek P, Beekhuizen H, Wolterbeek R, van den Barselaar M, van der Reijden T, van der Meer J, van de Gevel J, Dijkshoorn L. 2006. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res. Microbiol. 157:360-366. http://dx.doi.org/10.1016/j.resmic.2005.09.011.
4. Kim SA, Yoo SM, Hyun SH, Choi CH, Yang SY, Kim HJ, Jang BC, Suh SI, Lee JC. 2008. Global gene expression patterns and induction of innate immune response in human laryngeal epithelial cells in response to Acinetobacter baumannii outer membrane protein A. FEMS Immunol. Med. Microbiol. 54:45-52. http://dx.doi.org/10.1111/j.1574-695X.2008.00446.x.
5. van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, Chen W. 2007. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect. Immun. 75:5597-5608. http://dx.doi.org/10.1128/IAI.00762-07.
6. Qiu H, KuoLee R, Harris G, Chen W. 2009. High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect. 11:946-955. http://dx.doi.org/10.1016/j.micinf.2009.06.003.
7. Harder J, Bartels J, Christophers E, Schroder JM. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713. http://dx.doi.org/10.1074/jbc.M008557200.
8. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, Liu L, Ganz T. 2002. Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J. Investig. Dermatol. 118:275-281. http://dx.doi.org/10.1046/j.0022-202x.2001.01651.x.
9. Ganz T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3:710-720. http://dx.doi.org/10.1038/nri1180.
10. Zasloff M. 2002. Antimicrobial peptides in health and disease. N. Engl. J. Med. 347:1199-1200. http://dx.doi.org/10.1056/NEJMe020106.
11. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, Oppenheim JJ. 1999. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-528. http://dx.doi.org/10.1126/science.286.5439.525.
12. Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, Marotta ML, Mirza M, Jiang B, Kiser P, Medvik K, Sieg SF, Weinberg A. 2003. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17:F39-F48. http://dx.doi.org/10.1097/00002030-200311070-00001.
13. Feng Z, Dubyak GR, Lederman MM, Weinberg A. 2006. Cutting edge: human beta defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4. J. Immunol. 177:782-786. http://dx.doi.org/10.4049/jimmunol.177.2.782.
14. Takeda K, Akira S. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1-14. http://dx.doi.org/10.1093/intimm/dxh186.
15. Pasare C, Medzhitov R. 2004. Toll-like receptors: linking innate and adaptive immunity. Microbes Infect. 6:1382-1387. http://dx.doi.org/10.1016/j.micinf.2004.08.018.
16. Funderburg N, Lederman MM, Feng Z, Drage MG, Jadlowsky J, Harding CV, Weinberg A, Sieg SF. 2007. Human-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. U. S. A. 104:18631-18635. http://dx.doi.org/10.1073/pnas.0702130104.
17. Bist P, Dikshit N, Koh TH, Mortellaro A, Tan TT, Sukumaran B. 2014. The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii Infection. Infect. Immun. 82:1112-1122. http://dx.doi.org/10.1128/IAI.01459-13.
18. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrugresistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 50:4114-4123. http://dx.doi.org/10.1128/AAC.00778-06.
19. Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M, Snyder M. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 21:601-614. http://dx.doi.org/10.1101/gad.1510307.
20. Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, MacDonald IJ, Martin KM, Russo T, Campagnari AA, Hujer AM, Bonomo RA, Gill SR. 2008. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J. Bacteriol. 190:8053-8064. http://dx.doi.org/10.1128/JB.00834-08.
21. Feng Z, Jiang B, Chandra J, Ghannoum M, Nelson S, Weinberg A. 2005. Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J. Dent. Res. 84:445-450. http://dx.doi.org/10.1177/154405910508400509.
22. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA. 2000. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 68:2907-2915. http://dx.doi.org/10.1128/IAI.68.5.2907-2915.2000.
23. Ghosh SK, Gerken TA, Schneider KM, Feng Z, McCormick TS, Weinberg A. 2007. Quantification of human beta-defensin-2 and -3 in body fluids: application for studies of innate immunity. Clin. Chem. 53:757-765. http://dx.doi.org/10.1373/clinchem.2006.081430.
24. Koff JL, Shao MX, Kim S, Ueki IF, Nadel JA. 2006. Pseudomonas lipopolysaccharide accelerates wound repair via activation of a novel epithelial cell signaling cascade. J. Immunol. 177:8693-8700. http://dx.doi.org/10.4049/jimmunol.177.12.8693.
25. Shao MX, Nadel JA. 2005. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 102:767-772. http://dx.doi.org/10.1073/pnas.0408932102.
26. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen KJ, Rose-John S, Ludwig A. 2003. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102:1186-1195. http://dx.doi.org/10.1182/blood-2002-12-3775.
27. Gupta S, Ghosh SK, Scott ME, Bainbridge B, Jiang B, Lamont RJ, McCormick TS, Weinberg A. 2010. Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J. Biol. Chem. 285:36523-36531. http://dx.doi.org/10.1074/jbc.M110.133140.
28. Feucht E, DeSanti CL, Weinberg A. 2003. Selective induction of human beta-defensin nRNAs by Actinobacillus actinomycetemcomitans in primary and immortalized oral epithelial cells. Oral Microbiol. Immunol. 18:359-363. http://dx.doi.org/10.1046/j.0902-0055.2002.00097.x.
29. Krisanaprakornkit S, Kimball JR, Dale BA. 2002. Regulation of human beta-defensin-2 in gingival epithelial cells: the involvement of mitogenactivated protein kinase pathways, but not the NF-kappaB transcription factor family. J. Immunol. 168:316-324. http://dx.doi.org/10.4049/jimmunol.168.1.316.
30. Diamond G, Beckloff N, Weinberg A, Kisich KO. 2009. The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des. 15:2377-2392. http://dx.doi.org/10.2174/138161209788682325.
31. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N. 2003. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J. Immunol. 170:5583-5589. http://dx.doi.org/10.4049/jimmunol.170.11.5583.
32. Chung WO, Dale BA. 2008. Differential utilization of nuclear factorkappaB signaling pathways for gingival epithelial cell responses to oral commensal and pathogenic bacteria. Oral Microbiol. Immunol. 23:119-126. http://dx.doi.org/10.1111/j.1399-302X.2007.00398.x.
33. Steubesand N, Kiehne K, Brunke G, Pahl R, Reiss K, Herzig KH, Schubert S, Schreiber S, Folsch UR, Rosenstiel P, Arlt A. 2009. The expression of the beta-defensins hBD-2 and hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis. BMC Immunol. 10:36. http://dx.doi.org/10.1186/1471-2172-10-36.
34. Weinberg A, Krisanaprakornkit S, Dale BA. 1998. Epithelial antimicrobial peptides: review and significance for oral applications. Crit. Rev. Oral Biol. Med. 9:399-414. http://dx.doi.org/10.1177/10454411980090040201.
35. Dunsche A, Acil Y, Dommisch H, Siebert R, Schroder JM, Jepsen S. 2002. The novel human beta-defensin-3 is widely expressed in oral tissues. Eur. J. Oral Sci. 110:121-124. http://dx.doi.org/10.1034/j.1600-0722.2002.11186.x.
36. March C, Regueiro V, Llobet E, Moranta D, Morey P, Garmendia J, Bengoechea JA. 2010. Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response. PLoS One 5:e10033. http://dx.doi.org/10.1371/journal.pone.0010033.
37. Blobel CP. 2005. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6:32-43. http://dx.doi.org/10.1038/nrm1548.
38. Harris RC, Chung E, Coffey RJ. 2003. EGF receptor ligands. Exp. Cell Res. 284:2-13. http://dx.doi.org/10.1016/S0014-4827(02)00105-2.
39. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164:769-779. http://dx.doi.org/10.1083/jcb.200307137.
40. Pahl R, Brunke G, Steubesand N, Schubert S, Bottner M, Wedel T, Jurgensen C, Hampe J, Schafer H, Zeissig S, Schreiber S, Rosenstiel P, Reiss K, Arlt A. 2011. IL-1beta and ADAM17 are central regulators of beta-defensin expression in Candida esophagitis. Am. J. Physiol. Gastrointest. Liver Physiol. 300:G547-G553. http://dx.doi.org/10.1152/ajpgi.00251.2010.
41. Boughan PK, Argent RH, Body-Malapel M, Park JH, Ewings KE, Bowie AG, Ong SJ, Cook SJ, Sorensen OE, Manzo BA, Inohara N, Klein NJ, Nunez G, Atherton JC, Bajaj-Elliott M. 2006. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection. J. Biol. Chem. 281:11637-11648. http://dx.doi.org/10.1074/jbc.M510275200.
42. Hollox EJ, Armour JA, Barber JC. 2003. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am. J. Hum. Genet. 73:591-600. http://dx.doi.org/10.1086/378157.